{"id":"long-acting-beta-agonists","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Tremor"},{"rate":"5-10","effect":"Headache"},{"rate":"5-10","effect":"Nervousness or anxiety"},{"rate":"2-5","effect":"Palpitations"},{"rate":"2-5","effect":"Muscle cramps"},{"rate":"2-5","effect":"Tachycardia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"LABAs activate beta-2 adrenergic receptors, triggering a cascade that increases intracellular cAMP and leads to smooth muscle relaxation in the airways. This produces a prolonged bronchodilatory effect lasting 12-24 hours, making them suitable for maintenance therapy in chronic respiratory diseases. They are typically combined with inhaled corticosteroids to reduce exacerbations and improve lung function.","oneSentence":"Long-acting beta-agonists bind to beta-2 adrenergic receptors on airway smooth muscle to cause sustained bronchodilation and improve airflow.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:19:21.193Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Asthma maintenance therapy"},{"name":"Chronic obstructive pulmonary disease (COPD) maintenance therapy"}]},"trialDetails":[{"nctId":"NCT04157361","phase":"","title":"Pulmonary Condensate: Non-invasive Evaluation of Pulmonary Involvement in Asthma and Cystic Fibrosis.","status":"RECRUITING","sponsor":"The Institute of Molecular and Translational Medicine, Czech Republic","startDate":"2015-05-01","conditions":"Bronchial Asthma, Pulmonary Cystic Fibrosis","enrollment":450},{"nctId":"NCT07364188","phase":"","title":"Bronchodilator Response in COPD and Asthma: Correlation Between Spirometry, IOS Indices, and Dyspnea Relief","status":"NOT_YET_RECRUITING","sponsor":"Allergi- og Lungeklinikken, Elsinore","startDate":"2026-02-01","conditions":"Asthma Bronchiale, COPD, Bronchodilation","enrollment":120},{"nctId":"NCT07191535","phase":"PHASE2","title":"Effect of Linvemastat in Patients With Partially Controlled Asthma (syMMPonia)","status":"NOT_YET_RECRUITING","sponsor":"Foresee Pharmaceuticals Co., Ltd.","startDate":"2026-01-01","conditions":"Asthma (Diagnosis), Pulmonary Function, Moderate-to-Severe Asthma","enrollment":135},{"nctId":"NCT06795906","phase":"PHASE1","title":"A Safety, Pharmacokinetic, and Pharmacodynamic Study of Once Daily Inhaled AZD8630 in Adults With Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2025-01-28","conditions":"Asthma","enrollment":24},{"nctId":"NCT07114107","phase":"NA","title":"Vibroacoustic Therapy With Oscillating Positive Expiratory Pressure in the Treatment of Nasal Congestion","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-08","conditions":"Atopic Rhinitis, Atopic Asthma","enrollment":200},{"nctId":"NCT03692676","phase":"","title":"Characteristics of Pts Initiating Spiriva Respimat in Asthma","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2019-03-05","conditions":"Asthma","enrollment":116133},{"nctId":"NCT06869382","phase":"PHASE4","title":"ICS+LABA Vs. ICS+LABA+Omalizumab: Impact on Asthma Control and Gene Expression","status":"COMPLETED","sponsor":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","startDate":"2023-01-01","conditions":"Asthma Patients","enrollment":26},{"nctId":"NCT04696965","phase":"NA","title":"Appropriate Inhaler Use of Tiotropium As Add-on Therapy in Symptomatic Asthma","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2021-03-04","conditions":"Asthma","enrollment":48},{"nctId":"NCT03479138","phase":"","title":"Non-Eosinophilic Neutrophilic Asthma","status":"COMPLETED","sponsor":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","startDate":"2018-02-21","conditions":"Neutrophilic Asthma","enrollment":10},{"nctId":"NCT04742504","phase":"","title":"Interaction Between Benralizumab and Basophils in Eosinophilic Asthma","status":"COMPLETED","sponsor":"Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz","startDate":"2021-09-07","conditions":"Asthma; Eosinophilic","enrollment":20},{"nctId":"NCT05110976","phase":"PHASE1","title":"A Study to Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2021-12-16","conditions":"Asthma","enrollment":170},{"nctId":"NCT01108627","phase":"PHASE4","title":"Effect of Gly16Arg Polymorphism in ADRB2 Gene on Asthma Control in Children Receiving Long Acting Beta Agonists","status":"WITHDRAWN","sponsor":"Nemours Children's Clinic","startDate":"2010-10","conditions":"Safety of Long Acting Beta Agnoists","enrollment":""},{"nctId":"NCT00819637","phase":"PHASE4","title":"A Pilot Study to Determine the Most Effective Dose of Arformoterol for Treating Acute Asthmatic Patients","status":"TERMINATED","sponsor":"Henry Ford Health System","startDate":"2009-01","conditions":"Acute Asthma","enrollment":2},{"nctId":"NCT04503460","phase":"PHASE4","title":"Mechanisms of Adverse Effects of Long-Acting Beta-Agonists in Asthma","status":"UNKNOWN","sponsor":"Imperial College London","startDate":"2021-07-23","conditions":"Asthma","enrollment":24},{"nctId":"NCT00521222","phase":"NA","title":"Evaluating Long Acting Beta Agonists Used to Treat Asthma Among Those With Either Arg/Arg or Gly/Gly Genotypes","status":"COMPLETED","sponsor":"Columbia University","startDate":"2007-06","conditions":"Asthma","enrollment":90},{"nctId":"NCT05689931","phase":"","title":"Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma: Influence of Systemic IL-5 Targeting","status":"UNKNOWN","sponsor":"Region Skane","startDate":"2023-02-01","conditions":"Asthma","enrollment":80},{"nctId":"NCT04655170","phase":"PHASE4","title":"Feasibility, Safety and Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Hospitalized Patients With AECOPD","status":"UNKNOWN","sponsor":"University of Tennessee Graduate School of Medicine","startDate":"2020-12-09","conditions":"COPD Exacerbation","enrollment":60},{"nctId":"NCT04172701","phase":"","title":"A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-04-15","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":9284},{"nctId":"NCT04138758","phase":"","title":"Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2019-11-01","conditions":"COPD","enrollment":42953},{"nctId":"NCT03363698","phase":"","title":"MCT and Capsaicin Provocation Challenge in Diagnosis of Chronic Cough","status":"COMPLETED","sponsor":"Medical University of Warsaw","startDate":"2020-12-31","conditions":"Cough, Cough Variant Asthma, Upper-Airway Cough Syndrome","enrollment":55},{"nctId":"NCT03250689","phase":"PHASE2","title":"Randomized Study Evaluating the Effect of Danirixin on Neutrophil Extracellular Traps (NETs) in Chronic Obstructive Pulmonary Disease (COPD)","status":"TERMINATED","sponsor":"GlaxoSmithKline","startDate":"2017-11-15","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":19},{"nctId":"NCT00214539","phase":"NA","title":"Research in Severe Asthma (RISA) Trial","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2004-04","conditions":"Asthma","enrollment":34},{"nctId":"NCT03034967","phase":"PHASE2","title":"Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-04-25","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":614},{"nctId":"NCT03114969","phase":"","title":"Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2017-06-08","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":450},{"nctId":"NCT02135692","phase":"PHASE3","title":"A Phase 3a, Repeat Dose, Open-label, Long-term Safety Study of Mepolizumab in Asthmatic Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-05-29","conditions":"Asthma","enrollment":339},{"nctId":"NCT02658877","phase":"PHASE4","title":"Sputum-derived Cellular Targets After Xolair (Omalizumab)","status":"TERMINATED","sponsor":"NYU Langone Health","startDate":"2016-01","conditions":"Asthma","enrollment":3},{"nctId":"NCT01892787","phase":"PHASE4","title":"Effects of Particle Size in Small Airways Dysfunction","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2013-07","conditions":"Asthma","enrollment":17},{"nctId":"NCT02039011","phase":"PHASE4","title":"Ultra-long Acting Bronchodilator Therapy in Asthmatics","status":"COMPLETED","sponsor":"University of Dundee","startDate":"2014-02","conditions":"Asthma","enrollment":14},{"nctId":"NCT02446418","phase":"PHASE3","title":"A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2015-07-09","conditions":"Asthma","enrollment":423},{"nctId":"NCT00132730","phase":"PHASE2","title":"An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2004-06-01","conditions":"Lung Diseases, Pulmonary Disease, Chronic Obstructive","enrollment":604},{"nctId":"NCT03655392","phase":"NA","title":"Clinical, Functional and Inflammatory Evaluation in Asthmatic Patients After a Simple Short-Term Educational Program","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2015-07-01","conditions":"Asthma, Inflammation, Patient Relations, Nurse","enrollment":64},{"nctId":"NCT01290874","phase":"PHASE3","title":"Blacks and Exacerbations on Long Acting Beta Agonists (LABA) vs. Tiotropium (BELT)","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2011-03-30","conditions":"Asthma","enrollment":1070},{"nctId":"NCT01332461","phase":"","title":"Chronic Obstructive Pulmonary Disease (COPD)-Related Healthcare Utilization and Costs After Discharge From a Hospitalization or Emergency Department Visit on a Regimen of Fluticasone Propionate-Salmeterol Combination Versus Other Maintenance Therapies","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2009-11","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":5677},{"nctId":"NCT00706446","phase":"NA","title":"The Effects of Different Long-acting Bronchodilator Medications on Asthma Patients With Different Genetic Variations","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2008-06","conditions":"Asthma","enrollment":255},{"nctId":"NCT01875003","phase":"PHASE3","title":"A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2013-08-31","conditions":"Asthma","enrollment":348},{"nctId":"NCT01437995","phase":"PHASE4","title":"Long-acting Beta Agonist Step Down Study","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-03","conditions":"Asthma","enrollment":459},{"nctId":"NCT01765192","phase":"PHASE2","title":"Roflumilast Plus Montelukast in Adults With Severe Asthma","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2013-02","conditions":"Asthma","enrollment":64},{"nctId":"NCT01479595","phase":"PHASE2","title":"A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-02","conditions":"Asthma","enrollment":65},{"nctId":"NCT02661191","phase":"NA","title":"Vitamin D Deficiency and Asthma Exacerbation","status":"COMPLETED","sponsor":"University of Turin, Italy","startDate":"2012-10","conditions":"Asthma, Vitamin D Deficiency, Disease Exacerbation","enrollment":119},{"nctId":"NCT01478360","phase":"PHASE2","title":"Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2012-03","conditions":"Asthma","enrollment":46},{"nctId":"NCT01763463","phase":"","title":"WEUSKOP6416: Evaluating Pneumonia in Chronic Obstructive Pulmonary Disease (COPD) Subjects","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2012-07","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":1},{"nctId":"NCT01996124","phase":"PHASE4","title":"Acute Effect of Pulmonary Desufflation on Cardiac Performance in COPD Patients","status":"COMPLETED","sponsor":"University of Milan","startDate":"2013-11","conditions":"COPD, Hyperinflation, Right Cardiac Failure","enrollment":40},{"nctId":"NCT01125748","phase":"PHASE4","title":"A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term Therapy","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2010-05","conditions":"Allergic Asthma","enrollment":176},{"nctId":"NCT00670930","phase":"PHASE4","title":"Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-agonists","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-04","conditions":"Allergic Asthma","enrollment":36},{"nctId":"NCT00314574","phase":"PHASE3","title":"A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)","status":"COMPLETED","sponsor":"Genentech, Inc.","startDate":"2005-12","conditions":"Asthma","enrollment":850},{"nctId":"NCT00893009","phase":"NA","title":"The Effect on Small Airways of Addition of Theophylline as Inducer of Histone Deacilase Activity for Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Treated With Inhaled Steroids and Long Acting Beta Agonists","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2009-07","conditions":"COPD","enrollment":30},{"nctId":"NCT00668408","phase":"PHASE4","title":"LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria Careggi","startDate":"2008-05","conditions":"Lung Diseases, Obstructive, Chronic Heart Failure, Chronic Hypoxemia","enrollment":1000}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ACUTE MYOCARDIAL INFARCTION"},{"count":1,"reaction":"BRAIN NEOPLASM"},{"count":1,"reaction":"CARDIOVASCULAR DISORDER"},{"count":1,"reaction":"CONDITION AGGRAVATED"},{"count":1,"reaction":"DEATH"},{"count":1,"reaction":"DEEP VEIN THROMBOSIS"},{"count":1,"reaction":"MENTAL DISORDER"},{"count":1,"reaction":"RESPIRATORY DISORDER"},{"count":1,"reaction":"WEIGHT DECREASED"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"long-acting beta-agonists","genericName":"long-acting beta-agonists","companyName":"Genentech, Inc.","companyId":"genentech-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Long-acting beta-agonists bind to beta-2 adrenergic receptors on airway smooth muscle to cause sustained bronchodilation and improve airflow. Used for Asthma maintenance therapy, Chronic obstructive pulmonary disease (COPD) maintenance therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}